Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study

por Board, R E, Ellison, G, Orr, M C M, Kemsley, K R, McWalter, G, Blockley, L Y, Dearden, S P, Morris, C, Ranson, M, Cantarini, M V, Dive, C, Hughes, A
Publicado 2009

Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer

por Jänne, P A, Smith, I, McWalter, G, Mann, H, Dougherty, B, Walker, J, Orr, M C M, Hodgson, D R, Shaw, A T, Pereira, J R, Jeannin, G, Vansteenkiste, J, Barrios, C H, Franke, F A, Crinò, L, Smith, P
Publicado 2015